Intuitive Surgical, Inc. (ISRG) compounding analysis
Full-size annual and quarterly year-over-year growth charts for revenue, EPS, operating cash flow, EBITDA, and free cash flow against the 15%, 20%, and 30% bars over 3-, 5-, and 10-year windows, with each metric's valuation multiple vs its own history.
Revenue · 10YDoes not currently clear the 15%+, 20%+, or 30%+ revenue bars over 10Y.
- Score
- 32/100
- 10Y CAGR
- 15.5%
- Median YoY
- 16.6%
- YoY volatility
- σ 12.6pp· uneven
- Quarters ≥ 20%
- 11 of 40
- Negative quarters
- 2
- Valuation vs own 10Y history
- P/S 12.9x · 10Y median 16.8x · 13th percentile · as of Aug 19, 2026
How this score is computed
- Quarters at or above 20%: 11 of 40 → 11 of 40 pts
- Steadiness (typical swing 12.6pp) → 16 of 25 pts
- Pace (median 16.6% YoY) → 2.1 of 20 pts
- Latest quarter (18.5% YoY) → 2.6 of 15 pts
- Score: 32 of 100
Annualized revenue (TTM) · by quarter, last 40
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
Across metrics · 10Y
| Metric | 10Y CAGR | Median YoY | YoY σ | Qtrs ≥ 20% | Neg. qtrs |
|---|---|---|---|---|---|
| RevenueRevenue | 15.5% | 16.6% | 12.6pp | 11 of 40 | 2 |
| EPSEPS | 16.4% | 20.4% | 104.9pp | 20 of 39 | 7 |
| Op cash flowOperating cash flow | 14.7% | 15.6% | 55.6pp | 16 of 40 | 12 |
| EBITDAEBITDA | 15.9% | 18.8% | 50.8pp | 19 of 40 | 7 |
| FCFFree cash flow | 13.7% | 23.7% | 303.9pp | 20 of 39 | 15 |
Reported figures over 10Y: annual-series CAGR, median and standard deviation (σ, percentage points) of quarterly year-over-year growth, quarters at or above 20%, and quarters with negative YoY. “—” means the window needs more comparable data.
Scores, qualification bars, and the 0–100 consistency methodology are documented on the compounders list page →
See also: ISRG on the compounders surface · All compounders, ranked